What amount sold does TA Realty Value-Add Fund XIV, L.P. report in Form D filings?

The latest linked filings report $1.8B sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was TA Realty Value-Add Fund XIV, L.P.'s most recent SEC filing?

TA Realty Value-Add Fund XIV, L.P.'s most recent Form D filing was on 2026-07-30.

How many investors does TA Realty Value-Add Fund XIV, L.P. have?

The most recent Form D filing lists 65 investor(s).

TA Realty Value-Add Fund XIV, L.P.

CIK: 0002077078·Pooled Investment Fund·BOSTON, MA·Limited Partnership·Founded 2025

Reported Sold

$1,785,685,000

Total Filings

Identified Offerings

Last Filed

Jul 30, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Jul 30, 2026Form D/A — Amendment

Reported sold: $1,785,685,000 · Target: Indefinite

Rule 506(b)·65 investors·Section 3(c), Section 3(c)(5), Section 3(c)(6)

Changed: Reported amount sold, Reported investors, Sales commissions

Jul 31, 2025Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·0 investors·Section 3(c), Section 3(c)(5), Section 3(c)(6)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

$2,168,980

Amendment Rate

50%

Latest reported sold across 1 identified offering

$1,785,685,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

General Partner TA Realty Value-Add Fund XIV GP, LLC

Related Person

Appears on 1 filing

Investment Manager and Managing Member of the General Partner TA Realty LLC

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 30, 2026	Amendment	Indefinite	$1,785,685,000	65
Jul 31, 2025	New	Indefinite	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026